| LB |
LandBridge Co LLC |
Class A Shares |
17% |
$239,109,127 |
+$41,715,312 |
4,005,849 |
+21% |
Morgan Stanley |
30 Jun 2025 |
| MCR |
MFS CHARTER INCOME TRUST |
Common Stock |
16% |
$42,526,808 |
|
6,676,108 |
|
Morgan Stanley |
30 Jun 2025 |
| WEA |
WESTERN ASSET PREMIER BOND FUND |
Common Shares of Beneficial Interest |
16% |
$20,004,371 |
+$1,645,395 |
1,855,693 |
+9% |
Morgan Stanley |
30 Jun 2025 |
| KTCC |
KEY TRONIC CORP |
Common Stock |
15% |
$5,621,814 |
-$471,954 |
1,592,582 |
-7.7% |
Morgan Stanley |
30 Sep 2025 |
| FPF |
First Trust Intermediate Duration Preferred & Income Fund |
Common Stock |
13% |
$151,036,759 |
|
7,887,037 |
|
Morgan Stanley |
30 Sep 2025 |
| BMN |
BlackRock 2037 Municipal Target Term Trust |
Common Shares of Beneficial Interest |
13% |
$19,106,998 |
+$1,719,868 |
799,456 |
+9.9% |
Morgan Stanley |
31 Mar 2025 |
| XOMA |
XOMA Royalty Corp |
Common Stock |
13% |
$37,100,087 |
+$10,076,968 |
1,525,497 |
+37% |
Morgan Stanley |
30 May 2025 |
| AGL |
agilon health, inc. |
Common Stock |
12% |
$192,768,956 |
|
50,200,249 |
|
Morgan Stanley |
31 Mar 2025 |
| OPPPRB |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.75% Series B Cumulative Preferred Shares |
12% |
$5,462,592 |
-$1,345,555 |
284,510 |
-20% |
Morgan Stanley |
30 Sep 2025 |
| ABUS |
Arbutus Biopharma Corp |
Common Shares |
11% |
$70,816,135 |
|
21,524,661 |
|
Morgan Stanley |
31 Dec 2024 |
| KVYO |
Klaviyo, Inc. |
Series A Common Stock |
10% |
$472,100,587 |
+$136,911,718 |
14,538,026 |
+41% |
Morgan Stanley |
31 Dec 2025 |
| GBAB |
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust |
Common Shares of Beneficial Interest |
10% |
$42,689,569 |
+$6,337,976 |
2,799,316 |
+17% |
Morgan Stanley |
31 Jul 2025 |
| BWG |
BrandywineGLOBAL-Global Income Opportunities Fund Inc |
Common Stock |
10% |
$15,049,966 |
-$1,590,758 |
1,733,867 |
-9.6% |
Morgan Stanley |
30 Sep 2025 |
| AUR |
Aurora Innovation, Inc. |
Class A Common Stock |
10% |
$1,028,459,244 |
+$128,746,958 |
140,692,099 |
+14% |
Morgan Stanley |
31 Mar 2025 |
| EMD |
WESTERN ASSET EMERGING MARKETS DEBT FUND INC. |
Common Stock |
9.7% |
$58,190,104 |
+$26,166,216 |
5,638,576 |
+82% |
Morgan Stanley |
30 Sep 2025 |
| AOD |
abrdn Total Dynamic Dividend Fund |
Common Stock |
9.5% |
$81,639,045 |
|
10,041,703 |
|
Morgan Stanley |
31 Mar 2025 |
| RPRX |
Royalty Pharma plc |
Class A Ordinary Shares |
9.2% |
$1,394,427,274 |
|
38,907,011 |
|
Morgan Stanley |
30 Jun 2025 |
| BLKB |
BLACKBAUD INC |
Common Stock |
9.2% |
$287,781,001 |
|
4,512,796 |
|
Morgan Stanley |
31 Mar 2025 |
| NPCT |
NUVEEN CORE PLUS IMPACT FUND |
Common Shares of Beneficial Interest |
9% |
$26,488,570 |
+$4,906,748 |
2,589,303 |
+23% |
Morgan Stanley |
31 Mar 2025 |
| OPP |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
Common Stock |
8.7% |
$16,351,256 |
|
1,998,931 |
|
Morgan Stanley |
31 Dec 2024 |
| BBNX |
Beta Bionics, Inc. |
Common Stock |
8.6% |
$74,305,196 |
+$16,109,185 |
3,739,567 |
+28% |
Morgan Stanley |
30 Sep 2025 |
| BGY |
BlackRock Enhanced International Dividend Trust |
Common Stock |
8.6% |
$45,671,295 |
|
8,243,916 |
|
Morgan Stanley |
31 Dec 2024 |
| WIW |
WESTERN ASSET INFLATION-LINKED OPPORTUNITIES & INCOME FUND |
Common Shares of Beneficial Interest |
8.5% |
$45,921,799 |
+$6,006,198 |
5,224,323 |
+15% |
Morgan Stanley |
30 Jun 2025 |
| FFA |
FIRST TRUST ENHANCED EQUITY INCOME FUND |
Common Stock |
8.5% |
$34,843,914 |
|
1,701,363 |
|
Morgan Stanley |
30 Jun 2025 |
| LUNG |
Pulmonx Corp |
Common Stock |
8.5% |
$17,530,110 |
+$2,200,052 |
3,390,737 |
+14% |
Morgan Stanley |
31 Mar 2025 |
| GROV |
Grove Collaborative Holdings, Inc. |
Class A Common Stock |
8.5% |
$5,050,025 |
+$631,950 |
3,412,179 |
+14% |
Morgan Stanley |
30 Jun 2025 |
| GUG |
Guggenheim Active Allocation Fund |
Common Shares |
8.4% |
$43,332,058 |
+$5,735,855 |
2,777,696 |
+15% |
Morgan Stanley |
30 Sep 2025 |
| NXDTPRA |
NEXPOINT DIVERSIFIED REAL ESTATE TRUST |
5.50% Series A Cumulative Preferred Shares |
8.4% |
$4,022,523 |
+$1,111,197 |
283,876 |
+38% |
Morgan Stanley |
30 Sep 2025 |
| ASA |
ASA Gold & Precious Metals Ltd |
Common Shares |
8.3% |
$71,693,213 |
+$16,861,316 |
1,565,354 |
+31% |
Morgan Stanley |
30 Sep 2025 |
| EMO |
ClearBridge Energy Midstream Opportunity Fund Inc. |
Common Stock |
8.3% |
$68,988,361 |
+$16,203,542 |
1,535,805 |
+31% |
Morgan Stanley |
30 Sep 2025 |
| NPCE |
NeuroPace Inc |
Common Stock |
8.3% |
$28,926,723 |
|
2,489,391 |
|
Morgan Stanley |
31 Dec 2024 |
| RIV |
RIVERNORTH OPPORTUNITIES FUND, INC. |
Common Stock |
8.2% |
$20,391,036 |
|
1,768,520 |
|
Morgan Stanley |
31 Mar 2025 |
| AFRM |
Affirm Holdings, Inc. |
Class A Common Stock |
8.1% |
$1,085,652,153 |
|
22,115,546 |
|
Morgan Stanley |
31 Dec 2024 |
| TERN |
Terns Pharmaceuticals, Inc. |
Common Stock |
8.1% |
$20,731,866 |
|
7,099,954 |
|
Morgan Stanley |
31 Mar 2025 |
| GLQ |
Clough Global Equity Fund |
Common Stock |
7.9% |
$9,119,510 |
|
1,480,440 |
|
Morgan Stanley |
31 Dec 2024 |
| APLS |
Apellis Pharmaceuticals, Inc. |
Common Stock |
7.7% |
$172,285,808 |
|
9,592,751 |
|
Morgan Stanley |
31 Dec 2024 |
| NFJ |
Virtus Dividend, Interest & Premium Strategy Fund |
Common Shares of Beneficial Interest |
7.7% |
$84,319,912 |
|
7,325,796 |
|
Morgan Stanley |
31 Mar 2025 |
| DOYU |
DouYu International Holdings Ltd |
Ordinary Shares / American Depositary Shares |
7.2% |
$16,357,738 |
|
2,175,260 |
|
Morgan Stanley |
30 Sep 2025 |
| IONQ |
IonQ, Inc. |
Common Stock |
7.1% |
$779,373,813 |
|
18,640,847 |
|
Morgan Stanley |
30 Jun 2025 |
| CACI |
CACI INTERNATIONAL INC /DE/ |
Common Stock |
7.1% |
$773,618,753 |
-$131,774,185 |
1,551,022 |
-15% |
Morgan Stanley |
30 Sep 2025 |
| WEX |
WEX Inc. |
Common Stock |
7.1% |
$314,713,075 |
|
2,419,753 |
|
Morgan Stanley |
31 Mar 2025 |
| MUE |
BLACKROCK MUNIHOLDINGS QUALITY FUND II, INC. |
Common Shares |
7.1% |
$15,004,622 |
|
1,561,355 |
|
Morgan Stanley |
31 Dec 2024 |
| AMG |
AFFILIATED MANAGERS GROUP, INC. |
Common Stock |
7% |
$472,898,962 |
|
1,983,387 |
|
Morgan Stanley |
30 Sep 2025 |
| EVH |
Evolent Health, Inc. |
Class A Common Stock |
7% |
$91,792,384 |
|
8,210,410 |
|
Morgan Stanley |
30 Jun 2025 |
| ODD |
Oddity Tech Ltd |
Class A Ordinary Shares |
6.9% |
$196,982,196 |
+$46,420,789 |
3,161,833 |
+31% |
Morgan Stanley |
30 Sep 2025 |
| GAXY |
GALAXY NEXT GENERATION, INC. |
Common Stock |
6.9% |
$48,360 |
|
4,836,001 |
|
Morgan Stanley |
31 Dec 2024 |
| TSHA |
Taysha Gene Therapies, Inc. |
Common Stock |
6.7% |
$44,506,820 |
-$2,034,437 |
16,858,644 |
-4.4% |
Morgan Stanley |
30 Jun 2025 |
| CEVA |
CEVA INC |
Common Stock |
6.7% |
$36,843,172 |
|
1,609,575 |
|
Morgan Stanley |
30 Jun 2025 |
| CCCC |
C4 Therapeutics, Inc. |
Common Stock |
6.7% |
$7,030,567 |
+$1,363,928 |
4,750,383 |
+24% |
Morgan Stanley |
30 Jun 2025 |
| NBB |
Nuveen Taxable Municipal Income Fund |
Common Shares of Beneficial Interest |
6.6% |
$30,508,656 |
|
1,944,465 |
|
Morgan Stanley |
30 Jun 2025 |
| LSAK |
LESAKA TECHNOLOGIES INC |
Common Stock |
6.6% |
$24,862,671 |
|
5,212,300 |
|
Morgan Stanley |
31 Dec 2024 |
| NET |
Cloudflare, Inc. |
Class A Common Stock |
6.5% |
$2,440,652,159 |
|
20,170,679 |
|
Morgan Stanley |
31 Mar 2025 |
| CNM |
Core & Main, Inc. |
Class A Common Stock |
6.5% |
$671,253,694 |
-$146,978,939 |
12,469,881 |
-18% |
Morgan Stanley |
30 Sep 2025 |
| STOK |
Stoke Therapeutics, Inc. |
Common Stock |
6.5% |
$32,588,288 |
|
3,426,739 |
|
Morgan Stanley |
31 Dec 2024 |
| NPFD |
Nuveen Variable Rate Preferred & Income Fund |
Common Shares of Beneficial Interest |
6.5% |
$30,415,184 |
+$18,885,182 |
1,567,793 |
+164% |
Morgan Stanley |
30 Jun 2025 |
| RGT |
ROYCE GLOBAL TRUST, INC. |
Common Stock |
6.5% |
$5,253,799 |
|
424,721 |
|
Morgan Stanley |
30 Jun 2025 |
| CSL |
CARLISLE COMPANIES INC |
Common Stock |
6.4% |
$1,145,773,945 |
|
2,776,355 |
|
Morgan Stanley |
30 Jun 2025 |
| NSIT |
INSIGHT ENTERPRISES INC |
Common Stock |
6.4% |
$228,626,168 |
+$43,512,922 |
2,015,926 |
+24% |
Morgan Stanley |
30 Sep 2025 |
| PCOR |
PROCORE TECHNOLOGIES, INC. |
Common Stock |
6.3% |
$692,335,002 |
|
9,494,446 |
|
Morgan Stanley |
30 Sep 2025 |
| ARMK |
Aramark |
Common Stock |
6.3% |
$553,634,861 |
|
16,751,433 |
|
Morgan Stanley |
31 Mar 2025 |
| CRTO |
Criteo S.A. |
American Depository Shares / Ordinary Shares |
6.3% |
$79,943,067 |
|
3,336,522 |
|
Morgan Stanley |
30 Jun 2025 |
| ANAB |
ANAPTYSBIO, INC |
Common Stock |
6.3% |
$48,136,102 |
|
1,845,002 |
|
Morgan Stanley |
30 Jun 2025 |
| HFRO |
HIGHLAND OPPORTUNITIES & INCOME FUND |
Common Shares of Beneficial Interest |
6.3% |
$18,236,898 |
+$546,322 |
3,480,324 |
+3.1% |
Morgan Stanley |
30 Jun 2025 |
| FTF |
FRANKLIN LTD DURATION INCOME TRUST |
Common Shares of Beneficial Interest |
6.3% |
$16,007,423 |
|
2,553,018 |
|
Morgan Stanley |
31 Mar 2025 |
| PSF |
Cohen & Steers Select Preferred & Income Fund, Inc. |
Common Stock |
6.3% |
$14,718,575 |
|
761,831 |
|
Morgan Stanley |
31 Mar 2025 |
| QXO |
QXO, Inc. |
Common Stock |
6.2% |
$880,156,553 |
|
41,575,652 |
|
Morgan Stanley |
30 Jun 2025 |
| COLM |
COLUMBIA SPORTSWEAR CO |
Common Stock |
6.2% |
$178,030,246 |
|
3,404,020 |
|
Morgan Stanley |
30 Sep 2025 |
| KRNT |
Kornit Digital Ltd. |
Ordinary Shares |
6.2% |
$52,136,335 |
-$14,097,556 |
2,800,018 |
-21% |
Morgan Stanley |
31 Mar 2025 |
| NVST |
Envista Holdings Corp |
Common Stock |
6.1% |
$206,332,048 |
-$81,721,547 |
10,129,212 |
-28% |
Morgan Stanley |
30 Sep 2025 |
| TYG |
TORTOISE ENERGY INFRASTRUCTURE CORP |
Common Stock |
6.1% |
$45,402,272 |
+$3,664,425 |
1,045,172 |
+8.8% |
Morgan Stanley |
30 Jun 2025 |
| NML |
Neuberger Berman Energy Infrastructure & Income Fund Inc. |
Common Stock |
6.1% |
$30,534,158 |
|
3,458,002 |
|
Morgan Stanley |
30 Jun 2025 |
| KEX |
KIRBY CORP |
Common Stock |
6% |
$327,171,504 |
|
3,386,518 |
|
Morgan Stanley |
31 Mar 2025 |
| SPHR |
Sphere Entertainment Co. |
Class A Common Stock |
6% |
$108,581,660 |
+$29,635,464 |
1,747,934 |
+38% |
Morgan Stanley |
30 Sep 2025 |
| RMT |
ROYCE MICRO-CAP TRUST, INC. |
Common Stock |
6% |
$25,326,764 |
|
3,092,401 |
|
Morgan Stanley |
31 Mar 2025 |
| BRCB |
Black Rock Coffee Bar, Inc. |
Class A Common Stock |
6% |
$21,931,420 |
|
919,171 |
|
Morgan Stanley |
30 Sep 2025 |
| USPH |
U S PHYSICAL THERAPY INC /NV |
Common Stock |
5.9% |
$60,006,488 |
|
889,644 |
|
Morgan Stanley |
31 Dec 2024 |
| OPPPRA |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.375% Series A Cumulative Perpetual Preferred Stock |
5.9% |
$2,434,325 |
-$487,087 |
142,275 |
-17% |
Morgan Stanley |
30 Sep 2025 |
| ZYME |
ZYMEWORKS INC |
Common Stock |
5.8% |
$50,973,512 |
|
4,055,172 |
|
Morgan Stanley |
31 Mar 2025 |
| SMLR |
Semler Scientific, Inc. |
Common Stock |
5.8% |
$35,996,155 |
|
790,603 |
|
Morgan Stanley |
30 Jun 2025 |
| TE |
T1 Energy Inc. |
Common Stock |
5.8% |
$22,526,642 |
|
10,333,322 |
|
Morgan Stanley |
30 Sep 2025 |
| HIO |
WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC. |
Common Shares of Beneficial Interest |
5.8% |
$20,725,320 |
|
5,482,889 |
|
Morgan Stanley |
31 Dec 2024 |
| FDS |
FACTSET RESEARCH SYSTEMS INC |
Common Stock |
5.7% |
$967,147,681 |
|
2,167,472 |
|
Morgan Stanley |
30 Jun 2025 |
| LSTR |
LANDSTAR SYSTEM INC |
Common Stock |
5.7% |
$241,727,907 |
|
1,972,323 |
|
Morgan Stanley |
30 Sep 2025 |
| ASGI |
abrdn Global Infrastructure Income Fund |
Common Shares of Beneficial Interest |
5.7% |
$30,484,187 |
+$6,233,014 |
1,640,699 |
+26% |
Morgan Stanley |
31 Mar 2025 |
| LNTH |
Lantheus Holdings, Inc. |
Common Stock |
5.6% |
$193,758,848 |
|
3,777,712 |
|
Morgan Stanley |
30 Sep 2025 |
| FUN |
Six Flags Entertainment Corporation/NEW |
Common Stock |
5.6% |
$129,399,806 |
|
5,695,414 |
|
Morgan Stanley |
30 Sep 2025 |
| TBBB |
BBB FOODS INC |
Class A Common Shares |
5.6% |
$65,415,605 |
|
2,176,892 |
|
Morgan Stanley |
31 Dec 2024 |
| SLQT |
SelectQuote, Inc. |
Common Stock |
5.6% |
$24,321,715 |
|
10,134,048 |
|
Morgan Stanley |
30 Jun 2025 |
| GLO |
Clough Global Opportunities Fund |
Common Shares of Beneficial Interest |
5.6% |
$11,265,340 |
|
2,407,124 |
|
Morgan Stanley |
31 Dec 2024 |
| RERE |
ATRenew Inc. |
Class A Ordinary Shares |
5.6% |
$9,781,356 |
|
4,890,678 |
|
Morgan Stanley |
31 Dec 2024 |
| TRMB |
TRIMBLE INC |
Common Stock |
5.5% |
$1,036,258,531 |
|
13,064,278 |
|
Morgan Stanley |
30 Jun 2025 |
| ROIV |
Roivant Sciences Ltd. |
Common Shares |
5.5% |
$408,842,901 |
|
37,646,676 |
|
Morgan Stanley |
30 Jun 2025 |
| ARRY |
Array Technologies, Inc. |
Common Stock |
5.4% |
$67,137,385 |
|
8,237,716 |
|
Morgan Stanley |
30 Sep 2025 |
| TPB |
Turning Point Brands, Inc |
Common Stock |
5.4% |
$56,340,721 |
|
952,023 |
|
Morgan Stanley |
31 Dec 2024 |
| NBXG |
Neuberger Berman Next Generation Connectivity Fund Inc. |
Shares of Common Stock |
5.4% |
$51,115,724 |
|
4,245,492 |
|
Morgan Stanley |
31 Mar 2025 |
| URGN |
UroGen Pharma Ltd. |
Ordinary Shares |
5.4% |
$35,433,378 |
+$24,712,637 |
2,488,299 |
+231% |
Morgan Stanley |
30 Jun 2025 |
| MAPS |
WM TECHNOLOGY, INC. |
Class A Common Stock |
5.4% |
$6,381,515 |
|
5,647,358 |
|
Morgan Stanley |
31 Mar 2025 |
| NCZPRA |
Virtus Convertible & Income Fund II |
5.50% Series A Cumulative Preferred Shares |
5.4% |
$4,863,573 |
-$1,433,415 |
233,601 |
-23% |
Morgan Stanley |
30 Sep 2025 |
| ACP |
abrdn Income Credit Strategies Fund |
Common Shares |
5.3% |
$38,212,059 |
|
6,588,286 |
|
Morgan Stanley |
30 Sep 2025 |
| AXGN |
Axogen, Inc. |
Common Stock |
5.3% |
$37,659,361 |
|
2,330,406 |
|
Morgan Stanley |
31 Dec 2024 |